ANHUI HONGYU WUZHOU Medical Manufacturer Co.LTD.
Anhui Hongyu Wuzhou Medical Manufacturer Co.,Ltd. engages in the research, development, production, and sale of disposable sterile infusion medical devices in China. It offers disposable syringes, infusion (blood) devices, puncture needles, hypodermic needles, blood collection needles and sets, conventional syringes, and insulin syringes and pen needles, as well as infusion, blood administration,… Read more
ANHUI HONGYU WUZHOU Medical Manufacturer Co.LTD. (301234) - Total Assets
Latest total assets as of June 2025: CN¥853.46 Million CNY
Based on the latest financial reports, ANHUI HONGYU WUZHOU Medical Manufacturer Co.LTD. (301234) holds total assets worth CN¥853.46 Million CNY as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
ANHUI HONGYU WUZHOU Medical Manufacturer Co.LTD. - Total Assets Trend (2019–2024)
This chart illustrates how ANHUI HONGYU WUZHOU Medical Manufacturer Co.LTD.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
ANHUI HONGYU WUZHOU Medical Manufacturer Co.LTD. - Asset Composition Analysis
Current Asset Composition (December 2024)
ANHUI HONGYU WUZHOU Medical Manufacturer Co.LTD.'s total assets of CN¥853.46 Million consist of 62.8% current assets and 37.2% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 17.8% |
| Accounts Receivable | CN¥108.24 Million | 12.4% |
| Inventory | CN¥44.78 Million | 5.1% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥6.59 Million | 0.8% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2019–2024)
This chart illustrates how ANHUI HONGYU WUZHOU Medical Manufacturer Co.LTD.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: ANHUI HONGYU WUZHOU Medical Manufacturer Co.LTD.'s current assets represent 62.8% of total assets in 2024, an increase from 62.1% in 2019.
- Cash Position: Cash and equivalents constituted 17.8% of total assets in 2024, down from 21.0% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 2.0% in 2019.
- Asset Diversification: The largest asset category is accounts receivable at 12.4% of total assets.
ANHUI HONGYU WUZHOU Medical Manufacturer Co.LTD. Competitors by Total Assets
Key competitors of ANHUI HONGYU WUZHOU Medical Manufacturer Co.LTD. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
ANHUI HONGYU WUZHOU Medical Manufacturer Co.LTD. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - ANHUI HONGYU WUZHOU Medical Manufacturer Co.LTD. generates 0.55x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, ANHUI HONGYU WUZHOU Medical Manufacturer Co.LTD. generates $ 4.58 in net profit.
ANHUI HONGYU WUZHOU Medical Manufacturer Co.LTD. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.84 | 6.20 | 2.13 |
| Quick Ratio | 6.30 | 5.65 | 1.61 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥461.30 Million | CN¥ 421.39 Million | CN¥ 104.61 Million |
ANHUI HONGYU WUZHOU Medical Manufacturer Co.LTD. - Advanced Valuation Insights
This section examines the relationship between ANHUI HONGYU WUZHOU Medical Manufacturer Co.LTD.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.63 |
| Latest Market Cap to Assets Ratio | 0.12 |
| Asset Growth Rate (YoY) | 2.9% |
| Total Assets | CN¥872.67 Million |
| Market Capitalization | $108.04 Million USD |
Valuation Analysis
Below Book Valuation: The market values ANHUI HONGYU WUZHOU Medical Manufacturer Co.LTD.'s assets below their book value (0.12 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: ANHUI HONGYU WUZHOU Medical Manufacturer Co.LTD.'s assets grew by 2.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for ANHUI HONGYU WUZHOU Medical Manufacturer Co.LTD. (2019–2024)
The table below shows the annual total assets of ANHUI HONGYU WUZHOU Medical Manufacturer Co.LTD. from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥872.67 Million | +2.89% |
| 2023-12-31 | CN¥848.18 Million | +0.42% |
| 2022-12-31 | CN¥844.60 Million | +120.48% |
| 2021-12-31 | CN¥383.07 Million | +16.98% |
| 2020-12-31 | CN¥327.47 Million | +2.47% |
| 2019-12-31 | CN¥319.56 Million | -- |